Stock Earnings

Question 1

What are Artiva Biotherapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Artiva Biotherapeutics Inc has a total asset of $209, Net loss of $-65

Question 2

What are the key financial ratios for ARTV?

Accepted Answer

Artiva Biotherapeutics Inc's Current ratio is 9.5, has a Net margin is 0, sales per share of $0.

Question 3

How is Artiva Biotherapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Artiva Biotherapeutics Inc largest revenue segment is License and Development Support, at a revenue of 251,000 in the most earnings release.For geography, United States is the primary market for Artiva Biotherapeutics Inc, at a revenue of 251,000.

Question 4

Is Artiva Biotherapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Artiva Biotherapeutics Inc has a net loss of $-65

Question 5

Does Artiva Biotherapeutics Inc have any liabilities?

Accepted Answer

yes, Artiva Biotherapeutics Inc has liability of 22

Question 6

How many outstanding shares for Artiva Biotherapeutics Inc?

Accepted Answer

Artiva Biotherapeutics Inc has a total outstanding shares of 24.29

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	0	0	33	4	2
Revenue Growth (YoY)	-100%	-100%	725%	100%	--
Cost of Revenue	--	--	--	--	--
Gross Profit	--	--	--	--	--
Selling, General & Admin	20	17	13	20	12
Research & Development	65	50	50	43	42
Operating Expenses	86	67	64	64	55
Other Non Operating Income (Expenses)	0	-3	0	0	-18
Pretax Income	-79	-65	-28	-58	-71
Income Tax Expense	--	0	0	0	--
Net Income	-79	-65	-28	-58	-71
Net Income Growth	3%	132%	-52%	-18%	--
Shares Outstanding (Diluted)	24.48	11.25	23.28	23.28	23.28
Shares Change (YoY)	28.99%	-52%	0%	0%	--
EPS (Diluted)	-3.24	-5.8	-1.23	-2.52	-3.08
EPS Growth	-20%	371%	-51%	-18%	--
Free Cash Flow	-79	-55	-50	-57	-17
Free Cash Flow Per Share	-3.22	-4.88	-2.14	-2.44	-0.73
Gross Margin	--	--	--	--	--
Operating Margin	0%	0%	-90.9%	-1,475%	-2,650%
Profit Margin	0%	0%	-84.84%	-1,450%	-3,550%
Free Cash Flow Margin	0%	0%	-151.51%	-1,425%	-850%
EBITDA	-84	-65	-28	-58	-53
EBITDA Margin	0%	0%	-84.84%	-1,450%	-2,650%
D&A For EBITDA	2	2	2	1	0
EBIT	-86	-67	-30	-59	-53
EBIT Margin	0%	0%	-90.9%	-1,475%	-2,650%
Effective Tax Rate	--	0%	0%	0%	--

Artiva Biotherapeutics Inc (ARTV) Price

ARTV Stock Price Chart

ARTV Income

Follow-Up Questions